National Institute of Allergy and Infectious Diseases

Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.

The virus that causes AIDS loves to go after a particular group of white blood cells called T-cells, a key part of the immune system. T-cells have a protein on their surface that the virus attaches to and uses to invade the cell.

Creative Commons

A Seattle biotechnology firm is making waves on Wall Street. Juno Therapeutics had a splashy initial public offering Friday, and shares climbed more than 45 percent in its first day of trading.

Jake Ellison / KPLU

You may associate downtown Seattle with its shopping, hotels and offices, but the city's core also has a growing medical research community. From global-health focused non-profits to the University of Washington, it seems scientists all want to be near downtown.

The latest addition is a combination cancer research lab and bio-factory. Seattle Children’s Research Institute plans to open the new lab and "factory" in the Denny Triangle next month.